Personal and Home Care Products
CIRS Group
Chemicals
Cosmetic
Food
Medical Devices
Agrochemicals
CIRS Testing
Carbon Neutrality
Search
This article compiles and summarizes the latest developments in cosmetics regulations in China and globally as of May 2025, covering industry news, newly issued regulations, relevant policy adjustments, and regulatory requirements. It aims to assist enterprises in ensuring compliance and keeping up with global cosmetics regulatory trends.
In order to strengthen cosmetic regulation and safeguard consumer rights, the NMPA's Department of Cosmetics Supervision has provided answers to key industry concerns-such as labeling-based on current Chinese laws and technical standards. CIRS Group has compiled the information and translated them into English for your reference.
Following FAQs are all related to cosmetic safety assessment, CIRS Group has compiled the information and translated them into English for your reference.
On 6 June, 2025, the Scientific Committee on Consumer Safety (SCCS) of the European Union issued preliminary opinion (SCCS/1680/25) on Prostaglandin Analogues: Methylamido-Dihydro-Noralfaprostal (MDN) (CAS No. 155206-01-2), Isopropyl Cloprostenate (IPCP) (CAS No. 157283-66-4) and Dechloro Dihydroxy Difluoro Ethylcloprostenolamide (DDDE) (CAS No. 1185851-52-8). The deadline for comments is set for 18 August 2025.
Based on data retrieved from China’s National Medical Products Administration (NMPA), Shenzhen Dieckmann Biotechnology Co., Ltd. completed the filing of Ceramide EOS as a new cosmetic ingredient on June 10, 2025. At present, the associated technical specifications have not been made public, and the ingredient has not yet entered the post-filing monitoring period.
This article compiles data on cosmetic supervision as well as sampling inspections conducted within China and updates related information for May 2025.
On 2 May, 2025, the Scientific Committee on Consumer Safety (SCCS) of the European Union issued scientific advice (SCCS/1675/25) on Methyl Salicylate (CAS No. 119-36-8) which is the revision of the scientific advice been issued on 22 September, 2023 (SCCS/1654/23) .
In 2025, CIRS Group further expanded the platform function by incorporating global ingredient lists and usage restrictions, upgrading it to the Global Cosmetic Ingredient Regulatory Database (Global CosIng), which strive to facilitate the smooth compliance for enterprises engaged in global cosmetics trade. We are proud to officially launch the Global CosIng TODAY!
From May 28 to 30, 2025, CIRS Group was invited to participate in the 39th COSMOBEAUTY SEOUL, held at the COEX Convention & Exhibition Center in Seoul, South Korea. As one of the most influential beauty industry events in Asia, the exhibition brought together renowned cosmetics and beauty companies, industry experts, and professionals from around the world. The event covered a wide range of sectors including skincare, haircare, beauty devices, ingredients, and packaging, showcasing the latest technological innovations and market trends in the cosmetics industry.
On May, 2025, Scientific Advisory Group of Chemical Safety of Non-food and Non-medicinal Consumer Products (SAG-GS) issued opinion on 4-Methylbenzylidene Camphor (4-MBC) as a UV Filter in Cosmetic Product.
LEARN MORE